Loading
A phase 1 trial of CFI-400945 run by University Health Network, Toronto, completed.
A Study of CFI-400945 Fumarate in Patients With Advanced Cancer is a phase 1 interventional study registered as NCT01954316 by University Health Network, Toronto, with 46 participants enrolled, started 2014-03. Conditions recorded: Advanced Cancer. Interventions recorded: CFI-400945.
Shares CFI-400945, Treadwell Therapeutics, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares CFI-400945, Treadwell Therapeutics and the tag pipeline.
Shares CFI-400945, Treadwell Therapeutics and the tag pipeline.
Shares CFI-400945, Treadwell Therapeutics and the tag pipeline.
Shares Treadwell Therapeutics, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Treadwell Therapeutics, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Treadwell Therapeutics, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Treadwell Therapeutics and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/